Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quart... ( Tuesday November 13 2007 4:...)

Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results

Date:11/7/2007

Tuesday, November 13, 2007 4:30 p.m. EST http://www.westaim.com

CALGARY, Nov. 7 /PRNewswire-FirstCall/ - The Westaim Corporation will hold a webcast at 4:30 p.m. EST on Tuesday, November 13, 2007 regarding the Company's 2007 third quarter results.

In addition to standard disclosure over wire services, a news release and financial statements will be posted on the Westaim web site. To listen to the call live on the Internet, please go to http://www.westaim.com.

Drew Fitch, President & Chief Executive Officer, will participate on the call.

An audio file of the call will be archived and posted on the Westaim web site.

The Westaim Corporation's technology investments include iFire Technology Corp., which is developing a low-cost flat panel display technology, and a 74.8 per cent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX; NCS), which develops, manufactures and commercializes medical products that fight infection and inflammation based on its nanocrystalline silver technology. Westaim's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

SOURCE Westaim Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/27/2009)..., NEUILLY-SUR-SEINE,France,Nov.27/PRNewswire/--...cyclingteamdedicatedtoethicalsportinganddeveloping...thatitwillbecomeTeamGarmin-Transitionswiththeaddit...sitionsOpticalistheworld,sleadingmanufacturerofada...chnologyinthewidestselectionofspectaclelensessucha...

(Date:11/27/2009)...ring rates to bring unprecedented medical, economi...v. 27 (HealthDay News) -- The number of people wit...ble over the next 25 years, a new study predicts. ...4.1 million people with the disease, up from 23.7 ... treating people with diabetes will triple, the st...

(Date:11/27/2009)... Specialist manufacturers wh...ducts are saving millions of dollars by bringing i...rocess. Increasing numbers of pro-active medical m...rts at the concept stage of their projects, ensuri...ng design processes or potentially outdated techno...

(Date:11/26/2009)...n the next 25 years, the number of Americans livin...m 23.7 million in 2009 to 44.1 million in 2034. Ov...st triple, rising from $113 billion to $336 billio...ity, researchers based at the University of Chicag... , The number of those with diabetes covered by ...

(Date:11/26/2009)... No more letters from the No...ersonalized text messages from Santa , ...rt to increase operational efficiencies at the Nor...o help keep children all over the globe informed o...ves in Santa’s research department have iden...

Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3 Health News:Diabetes Cases Expected to Double in 25 Years 2 Health News:Diabetes Cases Expected to Double in 25 Years 3 Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2 Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3 Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4 Health News:Diabetes cases to double and costs to triple by 2034 2 Health News:Diabetes cases to double and costs to triple by 2034 3 Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2

[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor [0] Diabetes Cases Expected to Double in 25 Years [0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells [0] Diabetes cases to double and costs to triple by 2034 [1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes

... City, November 6, 2008Children born to mothers wi...f language development problems, according to a re...f Universit Laval,s School of Psychology. Details ...kills of 221 children whose mothers were diagnosed...

...The Fifth International Conference on Cell Therapy...comprehensive program dedicated to the evolving fi...cular diseases. The theme of this year,s meeting i... basic, core discussions on stem cell science as w...

...Maine, Nov. 6 Building on the successful,launch o...sses in Maine,the Maine State Chamber Purchasing A...s and Blue Shield have announced further additions...ith,varying levels of deductibles to consumer driv...

...N, Nov. 6 Today, at the annual,research conferenc...ICR), a,panel of leading scientists discussed the ...heir effects on cancer risk., Dietary supplements...ary supplements can be either protective or,harmfu...

... Lesley Stein, CPT fitness expert...uce their risk of memory loss through an education...ss to brain activity. , ... an effort to combat memory loss, especially for t...

...Nov. 6 US Oncology, Inc. ("US Oncology" or,"the C...services companies,reported revenue of $821.7 mill...54.8 million, net income of $3.9 million and opera...nue of $2.5,billion, EBITDA of $(217.7) million, A...

Pregnancy diabetes doubles the risk of language delay in children 5th Annual Global Conference on Stem Cell Therapy to be held Jan. 13-16, 2009 in NYC Chamber BlueOptions Insurance Adds to its Options and Benefits for 2009 Suite of Insurance Plans Meeting Small Business Needs Scientists Debate Dietary Supplements and Cancer Risk at AICR Conference Leading London Neurosurgeon, Sim Farar, Partners with Los Angeles Fitness Guru to Help Baby Boomers Decrease Memory Loss US Oncology Reports Third Quarter 2008 Results

(Date:11/25/2009)...,, WALTHAM,Mass.,Nov.25/PRNewswire/--Accordin...onmedicaltechnologymarketintelligence,thenearly$3b...toseerapidgrowthoverthenextfiveyearsdespitetherece... 2010 reportfindsthatthismarketwillremainhighlydy...ngspecializeddevicesinpreviouslyunderservedsegment...

(Date:11/25/2009)...,, DELFT,TheNetherlandsandJOHANNESBURG,Novemb...ivisionandPyxisDiscoveryannouncedtoday,thattheyhav...companies,services. , Pyxis,sworldclasscomput...upledwithiThemba,sservicedivisiontoprovidemedicina...throughPyxis,internationalclientnetwork.iThembaPh...

(Date:11/24/2009)...,, IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/...lyinvasivetreatmentsforaorticdisorders,announcedto...ceedingsin,thepatentinfringementlawsuitbroughtagai...eUnitedStatesDistrictCourtinIndianapolis,Indiana. ...ctwhiletheUnitedStatesPatentandTrademarkOffice(USP...

Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2 US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3 iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2 Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2 New Diabetes Drug Shows Promise in Trial 48220 1 New Diabetes Drug Shows Promise in Trial 48220 2 New Diabetes Drug Shows Promise in Trial 48220 3 Matrix Genomics Elizabeth Corder PhD Gene Variation in the LRRK2 Gene and High Risk for Parkinson 26apos 3Bs Disease 12529 1 Matrix Genomics Elizabeth Corder PhD Gene Variation in the LRRK2 Gene and High Risk for Parkinson 26apos 3Bs Disease 12529 2 Matrix Genomics Elizabeth Corder PhD Gene Variation in the LRRK2 Gene and High Risk for Parkinson 26apos 3Bs Disease 12529 3 Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 1 Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 2 Rep Lewis Commends Kidney Care Partners Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients in Georgia 48216 3

[0] US Trauma Fixation Device Market Not Seeing Signs of Slowdown [0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering [0] Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement

...SS WIRE)--Apr 17, 2007 - GenVec, Inc.,(Nasdaq:GNVC...at,the 97th annual meeting of the American Associa...t the use of adenovector systems,to deliver the ge...enVec,s lead product candidate, TNFerade(TM) biolo...which contains the gene for,TNF(alpha), a potent i...

...WIRE)--Apr 17, 2007 - GTx, Inc. (NASDAQ:,GTXI) ann...hase II,Ostarine(TM) clinical trial of 60 elderly ...lin and glucose levels were reduced and,insulin re... 3 mg,dose of Ostarine compared to baseline. These...bset of prediabetic subjects., Data from the Phase...

Other Medicine Technology:GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 2 GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 3 GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial 2 GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial 3 GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial 4

GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial

...Allergy and Clinical Immunology (DACI) Reference L...ovement Act - 1988) licensed clinical laboratory t...vide comprehensive, high quality diagnostic allerg...rth America with asthma, allergy, and immunologic ...

...s a full-service, clinical reference laboratory se...tates and internationally. Unlike standard referen... research and development of new assays as well as...e assays with greater sensitivity, specificity, ef...

... natural substance created from chemically treated...ic agent registered with the FDA to help control b... material contains no chemical additives, thrombin...in contact with blood, it expands to 3-4 times its...

Microscissors: Straight

Medicine Products:

Dermatology, Allergy and Clinical Immunology (DACI) Reference Laboratory Specialty Laboratories ActCel Hemostatic Gauze Microscissors: Straight

Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quart...( Tuesday November 13 2007 4:...),Health